Furthermore, other groups have reported heightened ADAM17 activity in animal models of ischemic brain injury26–28, as well as stroke-induced increases in peripherally circulating levels of other ADAM17 substrates such as tumor necrosis factor alpha (TNFα) in human subjects29,30. This evidence concerns the gene TNF and stroke disorder.